Literature DB >> 21305873

Osteoarthritis and degenerative joint disease: local treatment options update.

Beniamino Palmieri1, Daniele Lodi, Stefania Capone.   

Abstract

This review describes intra-articular drugs therapy of arthritis and degenerative joint disease) with a range of old and recent molecules with specific focus on hyaluronic acid. HA is a cartilage matrix basic component secreted by chondrocytes: it prevents cartilage degradation by a complex interpherence between metalloproteinases, pain mediators and cells. Local injections of HA improve functional activity and pain management, particularly when it is combined with other selected drugs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21305873

Source DB:  PubMed          Journal:  Acta Biomed        ISSN: 0392-4203


  11 in total

1.  Chrysin Attenuates IL-1β-Induced Expression of Inflammatory Mediators by Suppressing NF-κB in Human Osteoarthritis Chondrocytes.

Authors:  Wenhao Zheng; Zhenyu Tao; Leyi Cai; Chunhui Chen; Chuanxu Zhang; Quan Wang; Xiaozhou Ying; Wei Hu; Hua Chen
Journal:  Inflammation       Date:  2017-08       Impact factor: 4.092

2.  Correlation between plasma, synovial fluid and articular cartilage Interleukin-18 with radiographic severity in 33 patients with osteoarthritis of the knee.

Authors:  Youhua Wang; Dawei Xu; Long Long; Xiaolong Deng; Ran Tao; Guicheng Huang
Journal:  Clin Exp Med       Date:  2014-08       Impact factor: 3.984

3.  Plumbagin Prevents IL-1β-Induced Inflammatory Response in Human Osteoarthritis Chondrocytes and Prevents the Progression of Osteoarthritis in Mice.

Authors:  Wenhao Zheng; Zhenyu Tao; Chunhui Chen; Chuanxu Zhang; Hui Zhang; Xiaozhou Ying; Hua Chen
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

4.  Effect of a Herbal-Leucine mix on the IL-1β-induced cartilage degradation and inflammatory gene expression in human chondrocytes.

Authors:  Nahid Akhtar; Mark Js Miller; Tariq M Haqqi
Journal:  BMC Complement Altern Med       Date:  2011-08-19       Impact factor: 3.659

5.  Downregulation of microRNA-23b-3p alleviates IL-1β-induced injury in chondrogenic CHON-001 cells.

Authors:  Qining Yang; Yongwei Zhou; Pengfei Cai; Weicong Fu; Jinhua Wang; Qiang Wei; Xiaofei Li
Journal:  Drug Des Devel Ther       Date:  2019-07-23       Impact factor: 4.162

6.  Cartilage Oligomeric Matrix Protein Levels in Synovial Fluid in Patients With Primary Knee Osteoarthritis And Healthy Controls: A Preliminary Comparative Analysis With Serum Cartilage Oligomeric Matrix Protein.

Authors:  Ruben Daniel Arellano; Lizette Sarai Aguilar; Rafael Argüello; Fernando Hernadez; Faviel Francisco Gonzalez; Javier Moran
Journal:  Arch Rheumatol       Date:  2017-04-04       Impact factor: 1.472

7.  Fuyuan Decoction Enhances SOX9 and COL2A1 Expression and Smad2/3 Phosphorylation in IL-1β-Activated Chondrocytes.

Authors:  Yudi Zhang; Rongheng Li; Yu Zhong; Sihan Zhang; Lingyun Zhou; Shike Shang
Journal:  Evid Based Complement Alternat Med       Date:  2015-12-07       Impact factor: 2.629

8.  Inhibition of Osteoarthritis-Related Molecules by Isomucronulatol 7-O-β-d-glucoside and Ecliptasaponin A in IL-1β-Stimulated Chondrosarcoma Cell Model.

Authors:  Gwan Ui Hong; Jung-Yun Lee; Hanna Kang; Tae Yang Kim; Jae Yeo Park; Eun Young Hong; Youn Ho Shin; Sung Hoon Jung; Hung-Bae Chang; Young Ho Kim; Young-In Kwon; Jai Youl Ro
Journal:  Molecules       Date:  2018-10-29       Impact factor: 4.411

9.  Overexpression of SOX9 alleviates the progression of human osteoarthritis in vitro and in vivo.

Authors:  Yuanming Ouyang; Wei Wang; Bing Tu; Yi Zhu; Cunyi Fan; Yanfeng Li
Journal:  Drug Des Devel Ther       Date:  2019-08-13       Impact factor: 4.162

10.  Arctigenin prevents the progression of osteoarthritis by targeting PI3K/Akt/NF-κB axis: In vitro and in vivo studies.

Authors:  Shangkun Tang; Weijun Zhou; Xinyang Zhong; Jianchen Xu; Huasong Huang; Xinnan Zheng; Jingkang Zhang; Shuyue Yang; Ping Shang; Qian Tang; Haixiao Liu
Journal:  J Cell Mol Med       Date:  2020-02-24       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.